133 related articles for article (PubMed ID: 9252648)
1. Effect of 6-diazo-5-oxo-L-norleucine (DON) on human carcinoid tumor cell aggregates.
Wu F; Bergström M; Stridsberg M; Orlefors H; Eriksson B; Oberg K; Watanabe Y; Långstrom B
Anticancer Res; 1997; 17(4A):2363-7. PubMed ID: 9252648
[TBL] [Abstract][Full Text] [Related]
2. Uptake of 14C- and 11C-labeled glutamate, glutamine and aspartate in vitro and in vivo.
Wu F; Orlefors H; Bergström M; Antoni G; Omura H; Eriksson B; Watanabe Y; Långström B
Anticancer Res; 2000; 20(1A):251-6. PubMed ID: 10769663
[TBL] [Abstract][Full Text] [Related]
3. Influence of glutamine on the growth of human glioma and medulloblastoma in culture.
Dranoff G; Elion GB; Friedman HS; Campbell GL; Bigner DD
Cancer Res; 1985 Sep; 45(9):4077-81. PubMed ID: 2862994
[TBL] [Abstract][Full Text] [Related]
4. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
Willis RC; Seegmiller JE
J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
[TBL] [Abstract][Full Text] [Related]
5. In vitro PET evaluations in lung cancer cell lines.
Xing T; Wu F; Brodin O; Fasth KJ; Långström B; Bergström M
Anticancer Res; 2000; 20(3A):1375-80. PubMed ID: 10928046
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
Rosenfeld H; Roberts J
Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
[TBL] [Abstract][Full Text] [Related]
7. A mechanism behind the antitumour effect of 6-diazo-5-oxo-L-norleucine (DON): disruption of mitochondria.
Wu F; Lukinius A; Bergström M; Eriksson B; Watanabe Y; Långström B
Eur J Cancer; 1999 Jul; 35(7):1155-61. PubMed ID: 10533463
[TBL] [Abstract][Full Text] [Related]
8. Limb development in mouse embryos: protection against teratogenic effects of 6-diazo-5-ox-L-norleucine (DON) in vivo and in vitro.
Greene RM; Kochhar DM
J Embryol Exp Morphol; 1975 Apr; 33(2):355-70. PubMed ID: 1176851
[TBL] [Abstract][Full Text] [Related]
9. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
Lebedeva ZI; Kabanova EA; Berezov TT
Biull Eksp Biol Med; 1985 Dec; 100(12):696-8. PubMed ID: 4074870
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor 1 signaling in human gastrointestinal carcinoid tumor cells.
Van Gompel JJ; Chen H
Surgery; 2004 Dec; 136(6):1297-302. PubMed ID: 15657590
[TBL] [Abstract][Full Text] [Related]
11. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
Huber KR; Rosenfeld H; Roberts J
Int J Cancer; 1988 May; 41(5):752-5. PubMed ID: 3366493
[TBL] [Abstract][Full Text] [Related]
12. A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy.
Leja J; Dzojic H; Gustafson E; Oberg K; Giandomenico V; Essand M
Clin Cancer Res; 2007 Apr; 13(8):2455-62. PubMed ID: 17438105
[TBL] [Abstract][Full Text] [Related]
13. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
Gilbert JA; Frederick LM; Ames MM
Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255
[TBL] [Abstract][Full Text] [Related]
14. Modulation of tumor induced angiogenesis in Ehrlich ascites tumor.
Ghosh S; Roy S; Banerjee M; Maity P
J Exp Clin Cancer Res; 2004 Dec; 23(4):681-90. PubMed ID: 15743040
[TBL] [Abstract][Full Text] [Related]
15. Transport and membrane binding of the glutamine analogue 6-diazo-5-oxo-L-norleucine (DON) in Xenopus laevis oocytes.
Taylor PM; Mackenzie B; Hundal HS; Robertson E; Rennie MJ
J Membr Biol; 1992 Jun; 128(3):181-91. PubMed ID: 1501246
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.
Manivannan S; Baxter VK; Schultz KL; Slusher BS; Griffin DE
J Virol; 2016 Oct; 90(20):9251-62. PubMed ID: 27489275
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
[TBL] [Abstract][Full Text] [Related]
19. Glutamine in the mechanism of ammonia-induced astrocyte swelling.
Jayakumar AR; Rao KV; Murthy ChR; Norenberg MD
Neurochem Int; 2006; 48(6-7):623-8. PubMed ID: 16517020
[TBL] [Abstract][Full Text] [Related]
20. 6-diazo-5-oxo-L-norleucine and azaserine as affinity inhibitors of glutamin(asparagin)ase.
Lebedeva ZI; Kabanova EA; Berezov TT
Biochem Int; 1986 Mar; 12(3):413-20. PubMed ID: 3707592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
